Long-Term Effects of Sirolimus on Human Skin TSC2-Null Fibroblast-Like Cells
March 2021
in “
Journal of Investigative Dermatology
”
Studysummary Sirolimus can reduce tumor cell size in TSC-related skin tumors, but continuous treatment is needed to maintain benefits.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on jidonline.org →